Evidence map›Paper›PMID 33495230›Full record

ArticleAntimicrobial agents and chemotherapy2021

Exploring Ubiquinone Biosynthesis Inhibition as a Strategy for Improving Atovaquone Efficacy in Malaria.

I B Verdaguer, M Crispim, C A Zafra, R A C Sussmann, N L Buriticá, H R Melo, M F Azevedo, F G Almeida, E A Kimura, A M Katzin

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Antimicrobial agents and chemotherapy · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

I B Verdaguer *Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
M Crispim *Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.ORCID 0000-0002-2856-5471
C A ZafraDepartment of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
R A C SussmannCenter for Environmental Sciences, Institute of Humanities, Arts and Sciences, Federal University of Southern Bahia, Itabuna, Brazil.
N L BuriticáDepartment of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
H R MeloDepartment de Bioscience, Federal University of São Paulo, São Paulo, Brazil.
M F AzevedoDepartment de Bioscience, Federal University of São Paulo, São Paulo, Brazil.
F G AlmeidaDepartment of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
E A KimuraDepartment of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
A M KatzinDepartment of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil amkatzin@icb.usp.br.ORCID 0000-0002-4782-2162
Universidade de São Paulo · BRUniversidade Federal de São Paulo · BRUniversidade Federal do Sul da Bahia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atovaquone (AV) acts on the malaria parasite by competing with ubiquinol (UQH

Indexed as

MalariaUbiquinoneAtovaquoneHumansMitochondriaOxidation-ReductionAtovaquoneUbiquinone4-nitrobenzoateantimalarial agentsatovaquonebiosynthesismalariaoxygen levelsPlasmodium falciparumubiquinone

Identifiers

PMID33495230
PMCPMC8097429
OpenAlexW3123620172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.